Induction and characterization of cutaneous lymphocyte antigen on natural killer cells.
Cutaneous lymphocyte antigen (CLA) has been reported to be expressed mainly by memory/effector T lymphocytes infiltrating inflammatory skin lesions and cutaneous T-cell lymphoma. It has been suggested that CLA is a specific homing receptor, facilitating the T-cell migration into skin lesions, and also an indicator of the skin-homing T-cell subset. In the present study, we investigated the expression of CLA in natural killer (NK) cells defined phenotypically as surface CD3- and CD56+ cells in peripheral blood. CLA was definitely expressed on CD3-CD56+ cells at a level comparable to CD3+ cells in peripheral blood of normal Japanese volunteers. After in vitro stimulation of peripheral blood mononuclear cells with interleukin 2 (IL-2) and IL-12, there was a significant increase in the number and percentage of CLA+ NK cells but not CLA+ T cells (P < 0.01). To analyse the characteristics of CLA expressed by NK cells, we investigated a CLA+ NK-leukaemia cell line, NK-YS, established from a patient with NK leukaemia/lymphoma with skin infiltration. In the in vitro study, the CLA-expressing NK-leukaemic cell line bound to E-selectin-transfected cells and was inhibited by HECA 452 antibody or neuraminidase treatment of leukaemic cells. These findings suggest that CLA expressed by NK cells is a homing receptor for the E-selectin molecule and may explain skin infiltration by NK cells and NK lymphoma cells analogous to T cells. An NK-cell subset expressing CLA must play an important role in host defence against microorganisms and neoplasms in skin lesions.
Tsuchiyama
Junjiro
J
First Department of Internal Medicine, Niigata University School of Medicine, 1-754 Asahi-machi, Niigata 951, Japan. j-tutti@nifty.com
Yoshino
Tadashi
T
Toba
Ken
K
Harada
Naoki
N
Nishiuchi
Ritsuo
R
Akagi
Tadaatsu
T
Furukawa
Tatsuo
T
Takahashi
Masuiro
M
Fuse
Ichiro
I
Aizawa
Yoshifusa
Y
Harada
Mine
M
D015703:Antigens, CD / Q000276:immunology; D000951:Antigens, Neoplasm / Q000378:metabolism*; D015153:Blotting, Western; D016207:Cytokines / Q000378:metabolism; D019040:E-Selectin / Q000378:metabolism; D006801:Humans; D007376:Interleukin-2 / Q000378:metabolism; D007694:Killer Cells, Natural / Q000276:immunology*; D016410:Lymphoma, T-Cell, Cutaneous / Q000276:immunology*; D016201:Receptors, Lymphocyte Homing / Q000276:immunology; D012878:Skin Neoplasms / Q000276:immunology*; D013601:T-Lymphocytes / Q000276:immunology; D014407:Tumor Cells, Cultured
D015703:Antigens, CD; D000951:Antigens, Neoplasm; D016207:Cytokines; D019040:E-Selectin; D007376:Interleukin-2; D016201:Receptors, Lymphocyte Homing